F2 Ventures

Summary

In 2002 was created F2 Ventures, which is appeared as VC. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.

Among the various public portfolio startups of the fund, we may underline AlloVir, Cullinan Oncology, Cullinan Oncology Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the F2 Ventures, startups are often financed by New York Angels, MPM Capital, Jerusalem Global Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, UBS Asset Management, Redmile Group. In the next rounds fund is usually obtained by Venturra Capital, MPM Capital, Cento Ventures.

We also calculated 1 valuable employee in our database.

Comparing to the other companies, this F2 Ventures performs on 12 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2019. The important activity for fund was in 2015.